DXB ASX · Health Care

Dimerix Ltd

Announcements, last 12 months: 56
Price sensitive, last 12 months: 30
Followed on InvestorPA: Moderate (Among the 13% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
23 Oct 2026, 9:27 AM	New Data Supports Biological Rationale for DMX-200 in FSGS Price sensitive	AI summary
22 Oct 2026, 8:44 AM	2026 AGM Notice of Meeting, Letter of Access and Proxy Form
19 Oct 2026, 8:30 AM	Dimerix Announces Board Chair Transition
16 Oct 2026, 8:52 AM	DMX-200 First 100 Patients Complete Phase 3 Trial Treatment Price sensitive	AI summary
12 Oct 2026, 8:32 AM	Dimerix at Canaccord Drug & Device and Ignite Conferences
5 Oct 2026, 8:56 AM	First Patient Reaches Four Years in DMX-200 Clinical Program Price sensitive	AI summary
28 Sep 2026, 2:34 PM	Notification regarding unquoted securities - DXB
25 Sep 2026, 2:42 PM	Notification of 2026 Annual General Meeting Date
23 Sep 2026, 8:44 AM	Dimerix Presents at ASX SMIDcaps Conference 2026
23 Sep 2026, 8:36 AM	Dimerix Draws Down A$17M Under Non-Dilutive Funding Facility Price sensitive	AI summary

Sign in to see all DXB announcements.

Guidance history

27 Aug 2026	Dimerix Ltd expects to receive up to A$1.9 billion in upfront and potential milestone payments, plus royalties on net sales.
20 Aug 2026	Dimerix eligible for up to US$330 million in milestone payments
6 Aug 2026	Potential milestone payments and royalties exceeding $1.9 billion

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow DXB to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.